Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/GW642444 versus FF versus fluticasone propionate in persistent asthma
2010-019594-14Phase 3Completed
- Sponsor
- GSK
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate + vilanterol, fluticasone and fluticasone propionate in persistent asthma (3 arms), sponsored by GSK. Primary endpoint: Change from baseline in clinic visit trough FEV1 at Day 168. Started May 2010; status: completed.
02
Drugs
fluticasone propionate + vilanterolfluticasonefluticasone propionate
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2010-019594-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019594-14.